Successful treatment of vancomycin-resistant Enterococcus faecium endocarditis with linezolid in a renal transplant recipient with human immunodeficiency virus infection.
Infections with vancomycin-resistant Enterococci cause significant morbidity and mortality in hospitalized patients, including transplant recipients. We report the successful use of oral linezolid to treat a case of vancomycin-resistant Enterococcus faecium endocarditis in a renal transplant recipient with human immunodeficiency virus infection.
Archuleta
S
S
Division of Infectious Disease, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA. soa2002@med.cornell.edu
Murphy
B
B
Keller
M J
MJ
D000081:Acetamides / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D004697:Endocarditis, Bacterial / Q000150:complications / Q000188:drug therapy*; D016984:Enterococcus faecium / Q000187:drug effects*; D016908:Gram-Positive Bacterial Infections / Q000150:complications / Q000188:drug therapy*; D015658:HIV Infections / Q000150:complications; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology; D000069349:Linezolid; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000188:drug therapy; D023303:Oxazolidinones / Q000627:therapeutic use*; D020713:Vancomycin Resistance; D019562:Viral Load
D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D000069349:Linezolid